期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
High-gravity technology intensified Knoevenagel condensation-Michael addition polymerization of poly (ethylene glycol)-poly (n-butyl cyanoacrylate) for blood-brain barrier delivery
1
作者 Xingzheng Liu Chuanbo Fu +4 位作者 Manting Wang Jiexin Wang Haikui Zou Yuan Le Jianfeng Chen 《Chinese Journal of Chemical Engineering》 SCIE EI CAS CSCD 2022年第6期94-103,共10页
Poly(ethylene glycol)-poly(n-butyl cyanoacrylate)(PEG-PBCA)is a remarkable drug delivery carrier for permeating blood-brain barrier.In this work,a novel high-gravity procedure was reported to intensify Knoevenagel con... Poly(ethylene glycol)-poly(n-butyl cyanoacrylate)(PEG-PBCA)is a remarkable drug delivery carrier for permeating blood-brain barrier.In this work,a novel high-gravity procedure was reported to intensify Knoevenagel condensation-Michael addition polymerization of PEG-PBCA.A series of PEG-PBCA containing different block ratios were synthesized with narrow molecular weight distribution of polydispersity indexes less than 1.1.Furthermore,the reaction time reduced 60%compared to conventional stirred tank reactor process.Chemical structures of as-prepared polymers were characterized.In vitro drug delivery performance was evaluated.The cytotoxicity of PEG-PBCA to brain microvessel endothelial cells(BMVEC)decreases with the extension of the PEG chain and the shortening of the PBCA chain.The polymer cellular uptake to BMVECs was better after improving hydrophilicity by PEG block.Results of bloodbrain barrier permeability demonstrated that medium length of PBCA chain and short PEG chain are favorable for hydrophobic Nile red permeation,while long PEG chain and short PBCA chain are beneficial to delivery water-soluble doxorubicin hydrochloride(Dox).The average apparent permeability coeffi-cient increased 1.7 and 0.25 times than that of raw Nile red and Dox,respectively.High-gravity intensi-fied condensation polymerization should have great potential in brain drug delivery system. 展开更多
关键词 High-gravity technology Knoevenagel condensation-Michael addition polymerization Poly(ethylene glycol)-poly(n-butyl cyanoacrylate) Blood-brain barrier POLYMERIZATION Reactors
下载PDF
Percutaneous transcatheter super-selective renal arterial embolization with N-butyl cyanoacrylate for iatrogenic renal hemorrhage 被引量:1
2
作者 Xishan Li Guodong Chen Dongliang Zhu 《Journal of Interventional Medicine》 2022年第4期200-206,共7页
Background:To evaluate the safety and efficacy of percutaneous transcatheter super-selective renal arterial embolization(SRAE)with N-butyl cyanoacrylate(NBCA)for iatrogenic renal hemorrhage.Methods:Between January 201... Background:To evaluate the safety and efficacy of percutaneous transcatheter super-selective renal arterial embolization(SRAE)with N-butyl cyanoacrylate(NBCA)for iatrogenic renal hemorrhage.Methods:Between January 2014 and December 2019,45 patients(including 18 patients with coagulopathy),who underwent percutaneous transcatheter SRAE with NBCA for iatrogenic renal hemorrhage at our institution,were retrospectively reviewed.The technical success rate,clinical success rate,and embolization-related complications were analyzed.The values of estimated glomerular filtration rate(eGFR),serum creatinine(sCr),and serum urea(sUr)were analyzed at the time of pre-SRAE,post-SRAE,and last follow-up to evaluate the effects of NBCA-based SRAE on renal function.Results:Diagnostic renal arteriography revealed contrast extravasation in 18 patients and pseudoaneurysms in 27 patients.NBCA mixed with iodized oil in a 1:2–1:4 ratio was the sole embolic agent.No procedure-related mortality or major complications occurred.The technical and clinical success rates were both 100%.The values of eGFR,sCr and sUr were not found to be significantly different between pre-SRAE,post-SRAE and last follow-up(eGFR:91.52±21.17 vs.90.98±22.11 vs.92.14±23.51 mL/min/1.73 m^(2),p=0.729;sCr:74.73±11.08 vs.75.27±12.43 vs.73.95±10.14μmol/L,p=0.543;sUr:5.69±0.84 vs.5.71±0.96 vs.5.70±0.79,p=0.515,respectively).Conclusions:Percutaneous transcatheter SRAE with NBCA is a safe and effective treatment modality for iatrogenic renal hemorrhage with no deterioration of renal function. 展开更多
关键词 IATROGENIC Renal hemorrhage n-butyl cyanoacrylate Super-selective Renal arterial embolization
下载PDF
Safety of bronchial arterial embolization with n-butyl cyanoacrylate in a swine model
3
作者 Takami Tanaka Nobuyuki Kawai +7 位作者 Morio Sato Akira Ikoma Kouhei Nakata Hiroki Sanda Hiroki Minamiguchi Motoki Nakai Tetsuo Sonomura Ichiro Mori 《World Journal of Radiology》 CAS 2012年第12期455-461,共7页
AIM: To compare the efficacy and safety of bronchial artery embolization (BAE) with n-butyl cyanoacrylate (NBCA) and gelatin sponge particles (GSPs). METHODS: Six healthy female swine were divided into two groups to b... AIM: To compare the efficacy and safety of bronchial artery embolization (BAE) with n-butyl cyanoacrylate (NBCA) and gelatin sponge particles (GSPs). METHODS: Six healthy female swine were divided into two groups to be treated with BAE using NBCA-lipiodol (NBCA-Lp) and using GSPs. The occlusive durability, the presence of embolic materials, the response of the vessel wall, and damage to the bronchial wall and pulmonary parenchyma were compared. RESULTS: No animals experienced any major complication. Two days later, no recanalization of the bronchial artery was observed in the NBCA-Lp group, while partial recanalization was seen in the GSP group. Embolic materials were not found in the pulmonary artery or pulmonary vein. NBCA-Lp was present as a bubble-like space in bronchial branch arteries of 127-1240 μm, and GSPs as reticular amorphous substance of 107-853 μm. These arteries were in the adventitia outside the bronchial cartilage but not in the fine vessels inside the bronchial cartilage. No damage to the bronchial wall and pulmonary parenchyma was found in either group. Red cell thrombus, stripping of endothelial cells, and infiltration of inflammatory cells was observed in vessels embolized with NBCA-Lp or GSP. CONCLUSION: NBCA embolization is more potent than GSP with regard to bronchial artery occlusion, and both materials were present in bronchial branch arteries≥100 μm diameter. 展开更多
关键词 BRONCHIAL artery EMBOLIZATION EMBOLIC materials n-butyl cyanoacrylate Gelatin sponge LIPIODOL
下载PDF
经导管肝动脉α-氰基丙烯酸正丁酯胶栓塞治疗肝内出血 被引量:2
4
作者 谢坪 李刚 +1 位作者 程美雄 张天 《中国介入影像与治疗学》 CSCD 2014年第9期569-572,共4页
目的探讨以α-氰基丙烯酸正丁酯胶(NBCA)作为栓塞剂经导管肝动脉栓塞治疗肝内出血的价值。方法收集接受经导管肝动脉栓塞治疗的肝动脉出血患者7例,均使用NBCA作为栓塞剂,评价技术成功率、临床有效率及相关并发症。结果造影显示假性动脉... 目的探讨以α-氰基丙烯酸正丁酯胶(NBCA)作为栓塞剂经导管肝动脉栓塞治疗肝内出血的价值。方法收集接受经导管肝动脉栓塞治疗的肝动脉出血患者7例,均使用NBCA作为栓塞剂,评价技术成功率、临床有效率及相关并发症。结果造影显示假性动脉瘤6例,对比剂外溢1例。对7例患者均成功施行经导管肝动脉栓塞术,术后即刻造影假性动脉瘤和对比剂外溢征象消失,技术成功率100%;NBCA及超液化碘油混合剂用量为(0.76±0.24)ml;术后患者腹痛症状缓解,血红蛋白浓度升高,临床有效率100%。未发生手术相关并发症,随访1个月无再出血病例。结论采用NBCA胶行经导管肝动脉栓塞治疗肝内出血安全有效,具有重要临床应用价值。 展开更多
关键词 出血 α-氰基丙烯酸正丁酯胶 栓塞 治疗性
下载PDF
Posteroinferior Cerebellar Artery (PICA) Fusiform Aneurysm Ruptured Related with a Pure Arterial Malformation: Case Report and Technical Note (NBCA Embolization under Roadmap-Fluoroscopy)
5
作者 Maria Del Rosario Sosa-Martinez Guy G. Broc-Haro +2 位作者 Javier Valdes-Garcia Christopher Mader-Alba Daniel Juarez-Rebollar 《Open Journal of Modern Neurosurgery》 2021年第3期137-143,共7页
<strong>Background:</strong> The pure arterial malformation (PAM) lesion has been recently described as a vascular pathology characterized by the sole presence of coiled, sometimes ectatic, arterial loops.... <strong>Background:</strong> The pure arterial malformation (PAM) lesion has been recently described as a vascular pathology characterized by the sole presence of coiled, sometimes ectatic, arterial loops. 2% of the fusiform aneurysms are located in the vertebral-posterior inferior cerebellar arteries. <strong>Case Presentation:</strong> A 60 years old female with subarachnoid hemorrhage was diagnosed with a fusiform aneurysm in the right PICA related with a PAM in the digital subtraction angiography (DSA). With a negative super-selective Wada test, the patient was treated with embolization of the two lesions and the PICA for being in the same arterial territory with adhesive embolic liquid under roadmap fluoroscopy technique. The patient had a satisfactory clinical evolution and no added neurological deficit, so she was discharged 3 days after the treatment. <strong>Conclusion:</strong> These two vascular lesions located in the same artery are very rare and more in the PICA territory. It is important to make the best decision to treat them because of the potential complications;that’s why the procedure was supported with super-selective Wada test and neuromonitoring of the PICA territory. The injection of the mixture of NBCA and Lipiodol<span style="white-space:nowrap;"><sup>&#174;</sup></span> under roadmap fluoroscopy is very safe. 展开更多
关键词 Fusiform Aneurysm Pure Arterial Malformation n-butyl cyanoacrylate Roadmap Fluoroscopy
下载PDF
肝硬化门静脉高压消化道静脉曲张内镜下组织胶注射治疗专家共识(2022,长沙) 被引量:6
6
作者 中华医学会消化内镜学分会食管胃静脉曲张内镜诊断与治疗学组 令狐恩强 刘德良 《中华消化内镜杂志》 CSCD 2023年第1期12-23,共12页
肝硬化门静脉高压可引起全消化道静脉曲张。内镜下组织胶注射在消化道静脉曲张的治疗中起着重要作用,然而目前国内外尚无规范化治疗的相关共识。2022年,中华医学会消化内镜学分会食管与胃静脉曲张内镜诊断与治疗学组组织全国相关领域权... 肝硬化门静脉高压可引起全消化道静脉曲张。内镜下组织胶注射在消化道静脉曲张的治疗中起着重要作用,然而目前国内外尚无规范化治疗的相关共识。2022年,中华医学会消化内镜学分会食管与胃静脉曲张内镜诊断与治疗学组组织全国相关领域权威专家讨论,提出了肝硬化门静脉高压消化道静脉曲张内镜下组织胶注射治疗专家共识,以期规范该技术在消化道静脉曲张中的应用。本共识共分为肝硬化门静脉高压症消化道静脉曲张分型及诊断、组织胶注射治疗消化道静脉曲张的适应证等11个部分,共22条陈述。 展开更多
关键词 肝硬化 门静脉高压 消化道静脉曲张 内镜下组织胶注射 共识
原文传递
经皮经肝组织黏合剂栓塞联合部分脾栓塞治疗食管静脉曲张 被引量:7
7
作者 张春清 刘福利 +5 位作者 许洪伟 冯凯 徐麟 主余华 张俊勇 朱强 《中华肝脏病杂志》 CAS CSCD 北大核心 2007年第10期742-745,共4页
目的评价经皮经肝穿刺组织黏合剂(TH胶,α-氰基丙烯酸正丁酯)栓塞联合部分脾动脉栓塞(PSE)治疗食管静脉曲张的临床疗效。方法以食管下段曲张静脉和贲门胃底周围血管为靶血管,将TH胶灌注至食管下段及胃底曲张静脉内,使曲张静脉永久... 目的评价经皮经肝穿刺组织黏合剂(TH胶,α-氰基丙烯酸正丁酯)栓塞联合部分脾动脉栓塞(PSE)治疗食管静脉曲张的临床疗效。方法以食管下段曲张静脉和贲门胃底周围血管为靶血管,将TH胶灌注至食管下段及胃底曲张静脉内,使曲张静脉永久性闭塞,并联合PSE治疗食管静脉曲张出血患者84例,18例患者行急诊栓塞治疗。结果(1)81例栓塞成功,成功率96.4%,3例术后1个月因肝功能衰竭、腹腔感染和脑出血死亡。(2)TH胶栓塞到食管下段曲张静脉及胃底周围血管者38例;栓塞冠状静脉及胃底贲门周围曲张静脉但未达食管下段者31例;仅栓塞到胃冠状静脉主干者9例。术后其食管静脉曲张消失率分别为71.1%(27/38)、35.5%(11/31)、0(0/9),χ^2=18.3105,P〈0.01。(3)随访6~47(31.0±16.5)月,13例患者再出血,总出血率为16.7%。其中食管胃底型栓塞再出血率为7.9%(3/38);胃底型再出血率为12.9%(4/31);主干型再出血率为66.7%(6/9),χ^2值分别为12.6603和8.0765;P值均〈0.01。结论经皮经肝TH栓塞联合部分脾动脉栓塞不仅可控制急症出血,还可预防再出血,是治疗和预防门静脉高压食管静脉曲张出血的有效方法,术中应尽量将TH胶注射到食管下段曲张静脉和贲门胃底周围静脉内,以确保介入栓塞治疗的远期疗效。 展开更多
关键词 肝硬化 食管静脉曲张 栓塞 经皮经肝 α-氰基丙烯酸正丁酯(TH胶) 脾栓塞 部分
原文传递
Glubran-2胶栓塞术治疗肝硬化胃静脉曲张的疗效和安全性观察 被引量:2
8
作者 张世斌 宋燕明 +2 位作者 封丽 赵媛 丁惠国 《药物不良反应杂志》 CSCD 2014年第3期139-142,共4页
目的:初步评价Glubran-2胶栓塞术治疗肝硬化胃静脉曲张的疗效和安全性。方法2011年1月至2012年12月对北京佑安医院收治的49例肝硬化胃静脉曲张出血患者采用胃镜下Glubran-2胶栓塞术治疗。患者中男40例,女9例;年龄34-82(55±11... 目的:初步评价Glubran-2胶栓塞术治疗肝硬化胃静脉曲张的疗效和安全性。方法2011年1月至2012年12月对北京佑安医院收治的49例肝硬化胃静脉曲张出血患者采用胃镜下Glubran-2胶栓塞术治疗。患者中男40例,女9例;年龄34-82(55±11)岁;肝功能Child-Pugh分级A级19例,B级23例,C级7例;孤立胃静脉曲张( IGV)22例(44.9%),胃静脉曲张伴食管静脉曲张(GOV)27例(55.1%)。治疗方法:注射针管道内预充50%葡萄糖,静脉曲张部位注入Glubran-2胶后,再以50%葡萄糖将管道内剩余Glubran-2胶推入曲张静脉。依据曲张静脉体积1点或多点注射,每点注胶量1.0-3.0 ml,力求一次性完全栓塞曲张静脉。治疗后第1、3、6个月行胃镜检查观察曲张静脉消失情况。安全性评价指标为患者术后剑突下烧灼感、异位栓塞、发热,血常规(术前及术后3d检查),以及肝肾功能(术前及术后第1、3、6个月检查)。结果 IGV 患者 Glubran-2胶总用量为2.0-12.0 ml/例,平均用量(4.7±2.6)ml;GOV患者总用量为1.0-9.0 ml/例,平均用量(4.2±2.1)ml。49例患者中,曲张静脉消失者45例(91.8%),曲张静脉减轻者4例(8.2%);18例(36.7%)在治疗后1个月排胶,30例(61.3%)在治疗后3个月排胶,1例(2.0%)在治疗后6个月排胶。所有患者在注入胶后感到剑突下烧灼感。3例术后体温轻度升高,均未超过38℃。无一例患者发生异位栓塞。9例(18.4%)患者因排胶局部溃疡渗血,无一例因排胶致大出血。治疗前后血常规及肝肾功能各项指标无明显差异。结论 Glubran-2栓塞术治疗肝硬化胃静脉曲张有效且较为安全。 展开更多
关键词 栓塞 治疗性 食管和胃静脉曲张 肝硬化 氰基丙烯酸正丁酯
原文传递
α-氰基丙烯酸酯医用胶在大鼠肝脏短期创面局部反应的研究 被引量:3
9
作者 邵安良 许建霞 +1 位作者 王召旭 王春仁 《药物分析杂志》 CAS CSCD 北大核心 2012年第7期1162-1164,1161,共4页
目的:研究α-氰基丙烯酸酯医用胶短期肝创面局部反应。方法:试验采用SD雄性大鼠肝表面创伤模型,试验组和对照组分别采用在肝表面创伤部位喷涂医用胶和肝表面创伤部位不做处理方法,于术后5 min、1 d、3 d观察、取材,并进行组织学研究。结... 目的:研究α-氰基丙烯酸酯医用胶短期肝创面局部反应。方法:试验采用SD雄性大鼠肝表面创伤模型,试验组和对照组分别采用在肝表面创伤部位喷涂医用胶和肝表面创伤部位不做处理方法,于术后5 min、1 d、3 d观察、取材,并进行组织学研究。结果:大体观察:大鼠皮肤切口愈合良好,肝脏手术区大体正常。病理观察:试验组与对照组在术后1 d均有炎症反应,伴有中性粒细胞、淋巴细胞、吞噬细胞渗出,成纤维细胞增生,无坏死发生,但试验组在3 d时炎症较轻,且创伤修复较好。结论:在术后早期,没有发现α-氰基丙烯酸酯医用胶引起局部肝组织坏死,与对照组相比炎症较轻,创伤修复较好。 展开更多
关键词 粘合剂 生物医学有机材料 α-氰基丙烯酸酯医用胶 肝创面局部反应 肝脏表面创伤模型 局部组织坏死观察
原文传递
肝硬化门静脉高压消化道静脉曲张内镜下组织胶注射治疗专家共识(2022,长沙) 被引量:6
10
作者 中华医学会消化内镜学分会食管胃静脉曲张内镜诊断与治疗学组 令狐恩强 +4 位作者 刘德良 谭玉勇 楚毅 梁成柏 李陈婕 《中华胃肠内镜电子杂志》 2022年第4期193-206,共14页
肝硬化门静脉高压可引起全消化道静脉曲张,内镜下组织胶注射治疗在消化道静脉曲张的治疗中起着重要作用,然而目前国内外尚无其规范化治疗的相关共识。2022年,中华医学会消化内镜学分会食管与胃静脉曲张内镜诊断与治疗学组组织全国相关... 肝硬化门静脉高压可引起全消化道静脉曲张,内镜下组织胶注射治疗在消化道静脉曲张的治疗中起着重要作用,然而目前国内外尚无其规范化治疗的相关共识。2022年,中华医学会消化内镜学分会食管与胃静脉曲张内镜诊断与治疗学组组织全国相关领域权威专家讨论,提出了肝硬化门静脉高压消化道静脉曲张内镜下组织胶注射治疗专家共识,以期规范该技术在消化道静脉曲张中的应用。本共识共分为肝硬化门静脉高压消化道静脉曲张分型及诊断、组织胶注射治疗消化道静脉曲张的适应证等11个部分,共22条陈述。 展开更多
关键词 肝硬化 门静脉高压 消化道静脉曲张 内镜下组织胶注射治疗 共识
原文传递
NBCA组织胶与PVA微球联合弹簧钢圈在肝门部胆管癌术前PVE中的应用对比 被引量:2
11
作者 黄剑 葛乃建 +4 位作者 徐伟 蔡飞 张小锋 周静 杨业发 《临床放射学杂志》 北大核心 2021年第10期1993-1999,共7页
目的探究氰基丙烯酸正丁酯(NBCA)组织胶对比聚乙烯醇(PVA)微球联合弹簧钢圈在肝门部胆管癌术前门静脉栓塞(PVE)中促进预保留肝体积(FLR)增生的效果。方法回顾性分析2017年1月至2020年6月收治于东方肝胆外科医院肝门部胆管癌行术前PVE的6... 目的探究氰基丙烯酸正丁酯(NBCA)组织胶对比聚乙烯醇(PVA)微球联合弹簧钢圈在肝门部胆管癌术前门静脉栓塞(PVE)中促进预保留肝体积(FLR)增生的效果。方法回顾性分析2017年1月至2020年6月收治于东方肝胆外科医院肝门部胆管癌行术前PVE的63例患者临床资料,根据栓塞材料分为NBCA组26例及PVA联合弹簧钢圈组37例。比较两组患者FLR体积增加值(FLR_(PVE后)-FLR_(PVE前))、FLR体积增生率[(FLR_(PVE后)-FLR_(PVE前))/FLR_(PVE前)]、FLR体积增生速度(FLR体积增加值/PVE后天数)、FLR增生度[FLR_(PVE后)/总肝体积(TLV)-FLR_(PVE前)/TLV]、PVE术后并发症、胆管癌根治手术率、术后并发症、围手术期死亡率及术后90天内死亡率。结果NBCA组PVE术后(24.39±10.11)天FLR体积增加值(219.36±82.87)ml,PVA组PVE术后(26.16±11.79)天FLR体积增加值(154.74±121.57)ml(P=0.022)。NBCA组及PVA组FLR体积增生率分别为(47.96±23.28)%、(25.23±20.20)%(P<0.001),FLR体积增生速度分别为(10.91±6.39)ml/天、(6.79±6.85)ml/天(P=0.019),FLR增生度分别为(12.19±5.11)%、(9.18±5.02)%(P=0.023)。两组患者PVE术后并发症、胆管癌根治手术率及术后并发症均无明显统计学差异(P=0.457、P=0.317、P=0.551)。肝门部胆管癌根治术围手术期死亡PVA组2例(P=0.205),术后90天内NBCA组及PVA组各1例患者死亡(P=0.853)。结论NBCA及PVA联合弹簧钢圈PVE均可有效促进肝门部胆管癌术前FLR增生,且NBCA促进FLR增生效果优于PVA联合弹簧钢圈。 展开更多
关键词 氰基丙烯酸正丁酯组织胶 聚乙烯醇微球 肝门部胆管癌 门静脉栓塞 预保留肝体积
原文传递
Innovations in endoscopic ultrasound for portal hypertension and its role in managing complications in clinical practice:Lessons learned from a tertiary referral public hospital
12
作者 Cosmas R.A.Lesmana Kemal F.Kalista +5 位作者 Saut H.H.Nababan Juferdy Kurniawan Chyntia O.M.Jasirwan Andri S.Sulaiman Irsan Hasan Rino A.Gani 《Portal Hypertension & Cirrhosis》 2024年第1期31-35,共5页
Portal hypertension(PH)poses significant challenges.This paper presents an innovative study on the utilization of endoscopic ultrasound(EUS)for both the diagnosis and management of PH.Conducted at Dr.Cipto Mangunkusum... Portal hypertension(PH)poses significant challenges.This paper presents an innovative study on the utilization of endoscopic ultrasound(EUS)for both the diagnosis and management of PH.Conducted at Dr.Cipto Mangunkusumo National General Hospital in Jakarta,this retrospective case series included patients diagnosed with PH through clinical examination,imaging evaluation,and esophagogastroduodenoscopy.Exclusion criteria comprised a history of reduced blood consumption within the last 5 days,hepatocellular carcinoma,massive ascites,or elevated international normalized ratio(>1.4).EUS-guided portal pressure gradient(PPG)measurements were performed using an innovative standard manometer.The study involved 15 patients,with 14 having liver cirrhosis and 1 diagnosed with Budd–Chiari syndrome.Among them,nine patients experienced bleeding due to gastroesophageal varices.Small and large esophageal varices were identified in four and eight patients,respectively.Gastroesophageal varices type 1 were observed in two patients,and type 2 in four patients.Isolated gastric fundal varices type 1 were present in one patient.Based on EUS-PPG measurements,14 patients exhibited clinically significant portal hypertension.Seven patients underwent endoscopic band ligation and three underwent EUS-guided cyanoacrylate injection during the same session as the EUS-PPG measurement procedure.Notably,no adverse events,such as abdominal pain,perforation,or bleeding were observed during or after the procedure.EUS emerges as a promising and accurate tool for both diagnosis and management. 展开更多
关键词 cyanoacrylate injection endoscopic ultrasound liver cirrhosis portal hypertension portal pressure gradient
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部